Latest Stock Split Details
Key information about AmCad BioMed Corporation's most recent stock split
Split Date: 2016-05-27
Split Ratio: 103:100
Price Before Split: $35.95
Price After Split: $34.90
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.03 times more shares (a 103:100 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of AmCad BioMed Corporation's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2016-05-27 | 103:100 | No | $35.95 | $34.90 |
About AmCad BioMed Corporation
Company overview and industry information
AmCad BioMed Corporation (4188.TWO) operates in the Medical - Diagnostics & Research industry. The recent 103-for-100 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Medical - Diagnostics & Research
Go to AmCad BioMed Corporation Summary